Items where authors include "Mysler, E"

Article

Conaghan, P orcid.org/0000-0002-3478-5665, Cohen, S, Burmester, G et al. (11 more authors) (2022) Benefit-Risk Analysis of Upadacitinib compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis. Rheumatology and Therapy, 9 (1). pp. 191-206. ISSN 2198-6576

Conaghan, PG orcid.org/0000-0002-3478-5665, Mysler, E, Tanaka, Y et al. (9 more authors) (2021) Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program. Drug Safety, 44. pp. 515-530. ISSN 0114-5916

Smolen, JS, Landewé, R, Bijlsma, J et al. (46 more authors) (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases, 76 (6). pp. 960-977. ISSN 0003-4967

Weinblatt, ME, Mease, P, Mysler, E et al. (7 more authors) (2015) The efficacy and safety of subcutaneous clazakizumab in patients with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate: results from a multinational, phase IIb, randomized, double-blind, placebo/active-controlled, dose-ranging study. Arthritis and Rheumatology, 67 (10). pp. 2591-2600. ISSN 2326-5191